Human Topoisomerase II Function, Tyrosine Phosphorylation and Cell Cycle Checkpoints

Experimental Biology and Medicine

Volumn 217, Issue 3, 1998, Pages 327-334

  Kaufmann, William K ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CAFFEINE; CLASTOGEN; CYCLIN B; CYCLIN DEPENDENT KINASE; CYTARABINE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GENISTEIN; PHOSPHATASE; PIPERAZINEDIONE; PROTEIN P53; PROTEIN TYROSINE KINASE; SPARFOSIC ACID; TENIPOSIDE; TYROSINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; DEPHOSPHORYLATION; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE; GENETIC STABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NONHUMAN; PHOSPHORYLATION; REPLICON; TUMOR SUPPRESSOR GENE;

DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; G1 PHASE; G2 PHASE; GENISTEIN; HUMANS; PHOSPHORYLATION; TYROSINE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0031909821     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44240     Document Type: Article

References (54)

1. Yamashita Y, Kawada S, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharm 39:737-744, 1990.
2. Rose KM. DNA topoisomerases as targets for chemotherapy. FASEB J 2:2474-2478, 1988.
3. Finlay GJ, Holdaway KM, Baguley BC. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation. Oncology Res 6:33-37, 1994.
4. Markovits J, Junqua S, Goldwasser F, Venuat AM, Luccioni C, Beaumain J, Saucier JM, Bernheim A, Jacquemin-Sablon A. Genistein resistance in human leukemic CCRF-CEM cells: Selection of a diploid cell line with reduced DNA topoisomerase II beta isoform. Biochem Pharmacol 50:177-186, 1995.
5. Markovits J, Linnassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Lepecq JB, Larsen AK. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian topoisomerase II. Cancer Res 49:5111-5117, 1989.
6. lyn tyrosine kinase by ionizing radiation. J Biol Chem 269:20739-20743, 1994.
7. lyn kinase in human lyeloid leukemia cells. Biochemistry 34:1058-1063, 1995.
8. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, the MLL gene. J Natl Cancer Inst 86:1678-1680, 1994.
9. Hashimoto H, Chatterjee S, Berger NA. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res 55:4029-4035, 1995.
10. Phillips JW, Morgan WF. Illegitimate recombination induced by DNA double strand breaks in a mammalian chromosome. Mol Cell Biol 14:5794-5803, 1994.
11. Bender MA, Griggs HG, Walker PL. Mechanisms of chromosomal aberration production. I. Aberration induction by ultraviolet light. Mutat Res 20:387-402, 1973.
12. Felix CA, Lange BJ, Hosler MR, Fertala J, Bjornsti M. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 55:4287-4292, 1995.
13. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 266:1821-1828, 1994.
14. Kaufmann WK, Paules RS. DNA damage and cell cycle checkpoints. FASEB J 10:238-247, 1996.
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, and Craig RW. Participation of p53 protein in the cellular responses to DNA damage. Cancer Res 51:6304-6311, 1991.
16. White AE, Livanos EM, Tlsty TD. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Develop 8:666-677, 1994.
17. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, and Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Mol Gen 4:2025-2032, 1995.
18. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle D, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor MR, Arlett CF, Miki T, Weissman SM, Lovett M, Collina FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995.
19. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356, 1995.
20. Navas TA, Zhou Z, Elledge SJ. DNA polymerase E links the DNA replication machinery to the S phase checkpoint. Cell 80:29-39, 1995.
21. Murray AW. Creative blocks: Cell-cycle checkpoints and feedback controls. Nature 359:599-604, 1992.
22. Kaufmann WK. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer and Metastasis Reviews 14:31-41, 1995.
23. Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJP. P53 is overexpressed in fifty precent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 15:2269-2274, 1994.
24. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023, 1994.
25. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B. Waf1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174, 1994.
26. DiLeonardo A, Linke SP, Clarkin K, Wahl GM. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes and Development 8:2540-2551, 1994.
27. Nelson WG, Kastan MB. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823, 1994.
28. Tishler RB, Calderwood SK, Coleman CN, Price BD. Increases in sequence-specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53:2212-2216, 1993.
29. Terada Y, Tatsuka M, Jino S, Okayama H. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376:358-362, 1995.
30. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 55:4420-4424, 1995.
31. Paules RS, Levedakou EN, Wilson SJ, Innes C, Rhodes N, Tlsty TD, Galloway DA, Donehower LA, Tainsky MA, Kaufmann WK. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55:1763-1773, 1995.
32. Abrahams PJ, Schouten R, van Larr T, Houweling A, Terleth C, vander Eb AJ. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutat Res 336:169-180, 1995.
33. Kaufmann WK, Wilson SJ. DNA repair endonuclease activity during synchronous proliferation of diploid human fibroblasts. Mutat Res 236:107-117, 1990.
34. Kaufmann WK, Wilson SJ. G1 arrest and cell cycle dependent clastogenesis in UV-irradiated human fibroblasts. Mutation Res 314:67-76, 1994.
35. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene 10:1053-1059, 1995.
36. Wang XW, Yeh H, Schaeffer L, Roy R, Moincollin V, Egly JM, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris CC. P53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genetics 10:188-195, 1995.
37. Ford JM, Hanawalt PC. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV-resistance. Proc Natl Acad Sci USA 92:8876-8880, 1995.
38. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: A new explanation. Proc Natl Acad Sci USA 77:7315-7317, 1980.
39. Zampetti-Bosseler F, Scott D. Cell death, chromosome damage, and mitotic delay in normal human, ataxia telangiectasia, and retinoblastoma fibroblasts after X-irradiation. Inter J Radial Biol 39:547-558, 1981.
40. Little JB, Nagasawa H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aber- rations in human normal and ataxilangiectasia fibroblasts. Radiat Res 101:81-93, 1985.
41. Kaufmann WK, Cleaver JE. Mechanisms of inhibition of DNA replication by ultraviolet radiation in normal human and xeroderma pigmentosum fibroblasts. J Mol Biol 149:171-187, 1981.
42. Kaufmann WK, Boyer JC, Estabrooks LL, Wilson SJ. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes. Mol Cell Biol 11:3711-3718, 1991.
43. Kaufmann WK, Levedakou EN, Grady HL, Paules RS, Stein GH. Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res 55:7-11, 1995.
44. O'Connor PM, Ferris DK, Hoffman I, Jackman J, Draetta G, Kohn KW. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc Natl Acad Sci USA 91:9480-9484, 1994.
45. Nigg EA. Cyclin-dependent kinases: Key regulators of the eukaryotic cell cycle. BioEssays 17:471-480, 1995.
46. Morgan DO. Principles of CDK regulation. Nature 374:131-134, 1995.
47. cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res 50:3761-3766, 1990.
48. Galaktionov K, Jessus C, Beach D. Raf1 interaction with cdc25 phos- phatase ties mitogenic signal transduction to cell cycle activation. Genes Devel 9:1046-1058, 1995.
49. Chung TDY, Drake FH, Tan KB, Per SR, Crooke ST, Mirabelli CK. Characterization and immunological identification of cDNA clones encoding human DNA topoisomerase II isozymes. Proc Natl Acad Sci USA 86:9431-9435, 1989.
50. Nelson WG, Liu LF, Coffey DG. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma p62 cells. Nature (London) 322:187-189, 1986.
51. Downes CS, Clarke DJ, Mullinger AM, Gimenez-Abian JF, Creighton AM, Johnson RT. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372:467-470, 1994.
52. Kaufmann WK. Pathways of human cell post-replication repair. Carcinogenesis 10:1-11, 1989.
53. Byfield JE, Murnane J, Ward JF, Calabro-Jones P, Lynch M, Kulhanian F. Mice, men, mustard and methylated xanthines: The potential role of caffeine and related drugs in the sensitization of human tumors to alkylating agents. Br J Cancer 43:669-683, 1981.
54. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 52:6200-6208, 1992.